Silverback Therapeutics (@silverbacktx) header
Silverback Therapeutics (@silverbacktx) profile picture

Silverback Therapeutics

@silverbacktx

We are a clinical-stage biopharmaceutical company leveraging our technology platform to develop systemically delivered, tissue targeted therapeutics | $SBTX

 Seattle, WA
silverbacktx.com
Joined December 2017
  • Tweets122
  • Following173
  • Followers187
102Media
Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)Photo by Silverback Therapeutics (@silverbacktx)
Silverback Therapeutics retweeted
STAT (@statnews) profile picture
STAT
@statnews16 Nov 2021
Laura Shawver, Ph.D. @silverbacktx @lshawverO #STATSummit
Image from STAT (@statnews)
1
Silverback Therapeutics retweeted
STAT (@statnews) profile picture
STAT
@statnews15 Nov 2021
Then: Breaking biotech’s barriers Many brilliant women study biology. Why don’t more become professors, entrepreneurs, or CEOs? A panel of women who have made their mark in #biotech tell their stories. With: Sangeeta N. Bhatia, Agnieszka Czechowicz, & @lshawverO #STATSummit 4/7
1
1
2
Silverback Therapeutics retweeted
Nasdaq Exchange (@NasdaqExchange) profile picture
Nasdaq Exchange
@NasdaqExchange4 Dec 2020
Welcome to the @Nasdaq family, @SilverbackTX! 🎉🔔 Silverback Therapeutics is a clinical-stage biopharmaceutical company focused on developing systemically delivered, tissue targeted therapeutics for the treatment of cancer and other serious diseases. $SBTX #NasdaqListed
Image from Nasdaq Exchange (@NasdaqExchange)
Image from Nasdaq Exchange (@NasdaqExchange)
5
1
12
Silverback Therapeutics retweeted
Life Science WA (@LifeScienceWA) profile picture
Life Science WA@LifeScienceWA30 Apr 2020
Welcome to the Washington Life Science Community, @lshawverO! @silverbacktx new CEO aims to expand its oncology portfolio. bizjournals.com/seattle/news… via @PSBJ
1
3
Silverback Therapeutics retweeted
BioMedRealty (@BioMedRealty) profile picture
BioMedRealty@BioMedRealty6 May 2020
Congrats to our Seattle partners @silverbacktx on advancing their ongoing development of SBT6050, and their pipeline of ImmunoTAC™ programs. #lifesciences ow.ly/PUFA50zz2AE
Image from BioMedRealty (@BioMedRealty)
1
1
Silverback Therapeutics retweeted
Xconomy (@Xconomy) profile picture
Xconomy@Xconomy22 Apr 2020
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec - by @sarahdc xconomy.com/seattle/2020/04/…
4
3
Silverback Therapeutics retweeted
Life Science Washington EVS (@LSWInstitute) profile picture
Life Science Washington EVS@LSWInstitute23 Mar 2020
Congrats to @silverbacktx on their $78.5M raised in Series B funding! This support will allow the company to advance cancer antibody conjugates for solid tumors. Learn more here: buff.ly/33cai6r
1
1
Silverback Therapeutics retweeted
BioCentury (@BioCentury) profile picture
BioCentury@BioCentury12 Mar 2020
.@silverbacktx raised a $78.5M series B, led by @USVP_. The firm told @BioCentury that the biotech's innate immune system-stimulating IO therapy is differentiated by its local activation mechanism buff.ly/3aOlSHk
1
1
2
Silverback Therapeutics retweeted
BioSpace (@biospace) profile picture
BioSpace@biospace11 Mar 2020
Replying to @silverbacktx
@silverbacktx Raises $78.5 Million to Advance Cancer Antibody Conjugates for Solid Tumors #biospace #lifesciences #biotechnology #pharmaceuticals #biotech #pharma #cancer hubs.ly/H0nwTh40
1
1
Silverback Therapeutics retweeted
Xconomy (@Xconomy) profile picture
Xconomy@Xconomy11 Mar 2020
.@silverbacktx Adds $79M to Test HER2+ Tumor-Targeting Drug - by @sarahdc xconomy.com/seattle/2020/03/…
1
1
Silverback Therapeutics retweeted
Venture Funding News (@VCNewsDaily) profile picture
Venture Funding News@VCNewsDaily11 Mar 2020
Silverback Therapeutics Inks $78.5M in Series B led by U.S. Venture Partners. #vc #startups vcnewsdaily.com/silverback-t… via @VCNewsDaily @silverbacktx
1
1
Load more